PPP +10% . VNET +9% . USAT +9% . FHCO +9% . Top 10 Losers: NETE -33% . RATE -17% . LOXO -17% . SYN -15% . MSN -15% . SCOK -15% . NPSP -14% . MGPI -14% . CTP -14% . LOXO -15% . RADA -12% . Post your comment!
Gainers: AVNR +44% . ALR +20% . OTIV +11% . ETAK +7% . TAP +7% . HALO +6% . Losers: NPSP -13% . NETE -9% . TEX -8% . MDU -6% . Post your comment!
NPS Pharmaceuticals (NASDAQ: NPSP ) is set for a gap down at the open. Shares are off 8% premarket on good volume. On Friday, the an FDA Advisory Committee voted 8-5 in favor of approval of Natpara for the long-term treatment of hypoparathyroidism. Post your comment!
Sept 12 (Reuters) - A panel of outside advisers to the U.S. Food and Drug Administration on Friday voted 8-5 to recommend approval for Natpara, a hormone replacement therapy developed by NPS Pharmaceuticals Inc.
The FDA's Endocrinologic and Metabolic Drugs Advisory Committee votes 8-5 in favor of approval for NPS Pharmaceuticals ' ( NPSP ) Natpara for the long-term treatment of hypoparathyroidism. 2 comments!
NASDAQ halts trading in NPS Pharmaceuticals (NASDAQ: NPSP ) pending news from today's Ad Comm meeting reviewing the company's Natpara (rhPTH [1-84]) BLA. Post your comment!
Top 10 Gainers: NETE +136% . SYMX +24% . OTIV +23% . NPSP +21% . RCPT +20% . MTSL +21% . INVT +17% . LE +16% . AVNR +14% . MNOV +14 . Top 10 Losers: OTC:RXII -29% . PULS
The briefing docs for Friday's Ad Comm meeting apparently don't contain any smoking guns or red flags for NPS Pharmaceuticals (NASDAQ: NPSP ). Shares are up 20% premarket on robust volume. 1 comment!
Gainers: MNOV +21% . NPSP +18% . MNDL +16% . CAMT +14% . DRL +13% . OTIV +13% . LUNA +10% . LE +8% . VNET +7% . BDBD +6% . Losers: AU -12% . GTAT -8% . SCOK -7% . PULS -6% . WPCS -6% . Post your comment!
NEW YORK, Sept 10 (Reuters) - NPS Pharmaceuticals Inc rose sharply in premarket trading on Wednesday, after a preliminary review by the Food and Drug Administration said the company